Evidence map›Paper›PMID 35990742›Full record

ArticleSTAR protocols2022

A protocol to use

Julia G Saborio, Elizabeth E Young, Alexander S Chen, Renee D Read

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Pro-tumoral CaScientific reports · 2026
    Article
  2. Drosophila melanogaster as a Model System for Human Glioblastoma.Advances in experimental medicine and biology · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Julia G SaborioDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA; Graduate Program in Cancer Biology and Translational Oncology, Emory University, Atlanta, GA 30322, USA.
Elizabeth E YoungDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA.
Alexander S ChenDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA.
Renee D ReadDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA. Electronic address: renee.read@emory.edu.
Emory University · US

Funding

Mechanisms of RIOK2 function in glioblastomaR01NS100967 · NINDS · EMORY UNIVERSITY · PI READ, RENEE D · 2017 to 2021
$1.7M
NINDS NIH HHS R01 NS100967
6 · The paper itself

Abstract

This protocol describes a genetic model system we developed for glioblastoma (GBM) in

Indexed as

GlioblastomaGliomaAnimalsBrainDrosophila melanogasterHumansLarvaCancerDevelopmental biologyGeneticsModel organisms

Identifiers

PMID35990742
PMCPMC9385699
OpenAlexW4290694457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.